The APAC diabetes care devices market is expected to grow from US$ 6,350.97 million in 2022 to US$ 9,554.90 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2022 to 2028.
Technological advancements in the healthcare industry are encouraging market players to focus on research and development of insulin delivery devices. There are various methods to deliver insulin into the human body, including needles, insulin pens, and insulin pumps. Insulin pumps are small computerized diabetes management devices connected with a cannula under the skin to deliver a slow and continuous insulin level. Optimal diabetes management depends on accurate glucose monitoring devices. Technological advancements in glucose monitoring devices have resulted in smaller requirements for blood samples with improved accuracy. Furthermore, the ability to transfer data between the blood glucose (BG) meter and insulin delivery devices has been improved. A smart insulin pen is a reusable injector pen with an easy-to-use smartphone app that can assist diabetic people in managing insulin delivery. This intelligent device calculates and tracks doses while also providing patients with helpful reminders. In November 2020, Medtronic plc launched InPen, which relates to real-time Guardian Connect CGM data. The continuous research in insulin pens supports the growth of the diabetes care devices market during the forecast period. Pen needles and syringes are the most used device for injecting insulin into diabetic patients. Various manufacturers are developing innovative products to sustain in the highly fragmented needle market. Moreover, the easy regulatory approvals have led to mid-sized companies entering the market and competing with the local and established players. The development of pen needles with precise lubrication to reduce the pain sensation has been another focus of manufacturers during the research. Thus, the technological advancements and the increasing influx of new products into the market are expected to propel the growth of the market over the forecast years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC diabetes care devices market. The APAC diabetes care devices market is expected to grow at a good CAGR during the forecast period.
B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the APAC diabetes care devices market.
Technological advancements in the healthcare industry are encouraging market players to focus on research and development of insulin delivery devices. There are various methods to deliver insulin into the human body, including needles, insulin pens, and insulin pumps. Insulin pumps are small computerized diabetes management devices connected with a cannula under the skin to deliver a slow and continuous insulin level. Optimal diabetes management depends on accurate glucose monitoring devices. Technological advancements in glucose monitoring devices have resulted in smaller requirements for blood samples with improved accuracy. Furthermore, the ability to transfer data between the blood glucose (BG) meter and insulin delivery devices has been improved. A smart insulin pen is a reusable injector pen with an easy-to-use smartphone app that can assist diabetic people in managing insulin delivery. This intelligent device calculates and tracks doses while also providing patients with helpful reminders. In November 2020, Medtronic plc launched InPen, which relates to real-time Guardian Connect CGM data. The continuous research in insulin pens supports the growth of the diabetes care devices market during the forecast period. Pen needles and syringes are the most used device for injecting insulin into diabetic patients. Various manufacturers are developing innovative products to sustain in the highly fragmented needle market. Moreover, the easy regulatory approvals have led to mid-sized companies entering the market and competing with the local and established players. The development of pen needles with precise lubrication to reduce the pain sensation has been another focus of manufacturers during the research. Thus, the technological advancements and the increasing influx of new products into the market are expected to propel the growth of the market over the forecast years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC diabetes care devices market. The APAC diabetes care devices market is expected to grow at a good CAGR during the forecast period.
APAC Diabetes Care Devices Market Segmentation
The APAC diabetes care devices market is segmented based on type, end user, and country. Based on type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further categorized into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. Based on end user, the APAC diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the APAC diabetes care devices market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. China would dominate the market in 2022.B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the APAC diabetes care devices market.
Table of Contents
1. Introduction
3. Research Methodology
4. APAC Diabetes Care Devices Market - Market Landscape
5. APAC Diabetes Care Devices Market - Key Market Dynamics
6. Diabetes Care Devices Market- APAC Analysis
7. APAC Diabetes Care Devices Market Analysis - By Type
8. APAC Diabetes Care Devices Market Analysis- By End User
9. APAC Diabetes Care Devices Market - Country Analysis
10. Industry Landscape
11. Company Profiles
12. Appendix
List of Figures
List of Tables
Companies Mentioned
- B. Braun Melsungen AG
- BD
- Dexcom, Inc.
- Eli Lilly and Company.
- F. Hoffmann-La Roche Ltd.
- Insulet Corporation
- Medtronic
- Novo Nordisk A/S
- Tandem Diabetes Care Inc.
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 157 |
| Published | August 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 6350.97 Million |
| Forecasted Market Value ( USD | $ 9554.9 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 10 |
